Keyphrases
Pheochromocytoma
100%
Octreotate
100%
Paraganglioma
100%
Positron Emission tomography-CT
100%
68Ga-DOTA
100%
CT-MRI
33%
Mutation Carriers
22%
Conventional Imaging
22%
SDHx Genes
22%
Germ Cells
11%
Metastasis
11%
Asymptomatic mutation Carriers
11%
Consecutive Patients
11%
High Specificity
11%
Previously Treated
11%
Catecholamines
11%
Median Time
11%
Change Management
11%
Radiotherapy
11%
High Sensitivity
11%
Surveillance Program
11%
Imaging Follow-up
11%
Diagnostic Information
11%
Succinate Dehydrogenase
11%
Current Guidelines
11%
MRI Imaging
11%
Residual Disease
11%
Radionuclide Therapy
11%
Risk of Malignancy
11%
Prior Surgery
11%
Whole-body MRI
11%
Surveillance Strategy
11%
Osseous Lesions
11%
False-positive Findings
11%
Localized Treatment
11%
Incremental Value
11%
Management Impact
11%
SDHx
11%
Medicine and Dentistry
Positron Emission Tomography
100%
Tetraxetan
100%
Pheochromocytoma
100%
Paraganglioma
100%
Gallium 68
100%
Magnetic Resonance Imaging
55%
Southern District Health Board
22%
Conventional Imaging
22%
Diseases
22%
Cancer
11%
Metastatic Carcinoma
11%
Sensitivity and Specificity
11%
Catecholamine
11%
Histopathology
11%
False Positive Result
11%
Whole Body MRI
11%
Patient History of Surgery
11%
Minimal Residual Disease
11%
Clinical Imaging
11%
Radionuclide Therapy
11%
SDHD
11%
Succinate Dehydrogenase
11%
Germ Cell
11%
Radiation Therapy
11%